Skip to main content
    I

    InterCure Ltd. (INCR)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $4.78
    +0.09 (+1.92%)

    Market Cap: $75.47M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(8/16)
    Avg Surprise
    -1020.57%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Jul 30
    		$N/AN/AN/ABeat-
    Sep 25
    Reported Nov 18
    		$0.00N/A-100.00%Miss+100.0%
    Jun 25
    Reported Aug 20
    		$0.00N/A-100.00%Miss+100.0%
    Mar 25
    Reported Apr 29
    		$-1.58$0.01-15900.00%Miss-19900.0%
    Sep 24
    Reported Oct 3
    		$-0.01$0.01-229.27%Miss-135.3%
    Jun 24
    Reported Aug 30
    		$-0.01$-0.01+47.00%Beat-153.0%
    Mar 24
    Reported May 1
    		$-0.04N/A+72.02%Beat-165.8%
    Sep 23
    Reported Dec 26
    		$-0.01$-0.01+21.00%Beat-119.8%
    Jun 23
    Reported Aug 31
    		$0.03$0.01+200.00%Beat-66.7%
    Mar 23
    Reported May 15
    		$0.01$0.01+0.00%Beat+133.3%
    Dec 22
    Reported Mar 31
    		$0.05$0.05+2.67%Beat+638.0%
    Sep 22
    Reported Nov 15
    		$0.04$0.08-50.00%Miss+33.3%
    Jun 22
    Reported Aug 15
    		$0.09$0.08+12.50%Beat+125.0%
    Mar 22
    Reported Apr 6
    		$-0.03$0.05-160.00%Miss-126.3%
    Sep 21
    Reported Nov 15
    		$-0.01N/A-120.00%Miss-110.5%
    Jun 21
    Reported Aug 16
    		$0.03$0.04-25.00%Miss+152.6%
    Mar 21
    Reported May 10
    		$0.04$0.04+0.00%Beat+101.4%
    Dec 20
    Reported Mar 31
    		$0.11N/AN/ABeat-
    Sep 20
    Reported Sep 30
    		$0.09N/AN/ABeat-
    Jun 20
    Reported Jun 30
    		$-0.06N/AN/ABeat-
    Mar 20
    Reported Jun 29
    		$-2.77N/AN/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF1.98xFCF Yield50.38%
    Profitability
    Profit Margin-13.20%Operating Margin0.00%
    ROE-9.27%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-3.71x
    Current Ratio1.48xQuick Ratio0.97x
    Trading Statistics
    Beta0.64Avg Volume4.72K
    52-Week High$7.9552-Week Low$3.40

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.10
    SMA 20$5.19
    SMA 50$5.17
    SMA 200$4.65
    EMA 10$5.02
    EMA 20$5.12
    EMA 50$5.12
    EMA 200$5.14

    MACD

    Line: -0.09Signal: -0.03Hist: -0.07

    ADX

    ADX: 38.0+DI: 12.0-DI: 15.5

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down96.0
    PSAR$5.76

    Bollinger Bands

    Upper Band$5.62
    Lower Band$4.77
    %B Position1640%(Upper)
    Band Width0.02

    RSI (14-Day)

    Neutral
    39.6

    Momentum Oscillators

    Stoch %K18.6
    Stoch %D24.3
    Williams %R-86.4
    ROC (10d)-11.0%
    Momentum-0.59
    CCI (20d)-177.1
    MFI (14d)33.1

    Volatility Measures

    ATR (14d)$0.46(9.7%)
    StdDev (20d)0.21
    Hist Vol43.2%(High)

    Volume Flow

    VWAP$4.80
    OBV-1.5M
    AD Line111958661679.7B
    CMF (20d)-0.210

    Volume Metrics

    Avg Vol (20d)5.0K
    Vol Ratio1.2x
    VWMA (20d)$5.17

    Pivot Points

    R3$5.20
    R2$5.09
    R1$4.89
    Pivot Point$4.78
    S1$4.58
    S2$4.47
    S3$4.27

    Advanced Oscillators

    TSI-10.33
    Ultimate Osc33.2
    KST-17.68

    Financial Data

    QuarterMar 2026Sep 2025Jun 2025Mar 2025Sep 2024Jun 2024Mar 2024Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
    Total Revenue$70.09M$70.09M$65.01M$65.01M$56.56M$62.87M$62.87M$73.47M$102.44M$106.17M$105.61M$100.57M
    Cost of Revenue$69.86M$69.86M$44.89M$44.89M$56.36M$42.04M$42.04M$55.31M$69.80M$71.85M$79.75M$54.36M
    Gross Profit$239,500$239,500$20.11M$20.11M$195,500$20.83M$20.83M$18.16M$32.64M$34.33M$25.86M$46.21M
    Operating Expenses$16.72M$16.72M$17.25M$17.25M$39.06M$15.57M$15.57M$57.01M$25.92M$28.38M$27.43M$30.87M
    R&D$99,500$99,500$95,500$95,500$97,500$109,500$109,500$66,000$99,000$157,000$174,000$120,000
    SG&A$14.07M$14.07M$7.59M$7.59M$18.45M$9.53M$9.53M$10.49M$11.60M$12.62M$58.34M$13.98M
    Operating Income$-16,480,000$-16,480,000$2.86M$2.86M$-38,860,000$5.26M$5.26M$-26,667,000$5.82M$5.95M$-1,572,000$16.18M
    Interest Income$0$0$0$0$0$0$0$0$719,000$1.53M$8.12M$161,000
    Interest Expense$5.05M$5.05M$4.01M$4.01M$4.45M$4.52M$4.52M$5.06M$6.14M$5.71M$4.19M$4.40M
    Income Before Tax$-20,903,000$-20,903,000$-1,148,500$-1,148,500$-44,398,000$737,000$737,000$-31,731,000$403,000$1.77M$-8,725,000$11.95M
    Income Tax Expense$-3,417,000$-3,417,000$-242,500$-242,500$-8,005,000$740,000$740,000$1.94M$-3,322,000$1.68M$-13,991,000$3.64M
    Net Income$-17,003,000$-17,003,000$-852,000$-852,000$-34,614,000$716,500$716,500$-33,528,000$4.88M$214,000$5.27M$7.26M
    EBITDA$-34,796,500$-32,171,500$7.13M$7.13M$-47,054,000$7.20M$7.20M$-4,771,000$9.01M$10.66M$-6,087,000$19.06M
    EBIT$-36,520,000$-36,520,000$2.90M$2.90M$-49,100,000$5.16M$5.16M$-6,641,000$5.84M$7.48M$-1,572,000$16.34M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about INCR

    INCR Valuation and Fair Value

    Forward P/E
    6.2x
    P/FCF
    2.0x
    P/B
    0.1x
    See GNG's fair value

    INCR Profitability: Margins, ROIC and FCF

    Gross margin
    15.1%
    Operating margin
    0.0%
    Net margin
    -13.2%
    ROE
    -9.3%
    FCF margin
    9.0%
    FCF yield
    50.4%

    INCR Competitors

    CompanyTicker
    Electrocore LLCECOR
    CareCloud, Inc.CCLD
    Cognition Therapeutics IncCGTX
    LENSAR IncLNSR
    NeOnc Technologies Holdings, Inc. Common StockNTHI
    ProMIS Neurosciences Inc.PMN
    Nutriband IncNTRB
    OKYO Pharma LimitedOKYO

    Sector: Healthcare

    INCR Bull Case vs Bear Case

    Bull case

    • INCR grew quarterly revenue 23.9% year over year.

    Bear case

    • INCR has a -13.2% net profit margin.

    INCR Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -12.8%

    Frequently Asked Questions About INCR

    Does INCR pay dividends?

    InterCure Ltd. (INCR) does not currently pay a regular dividend.

    What is INCR's market cap?

    InterCure Ltd. (INCR) has a market capitalization of $75.47M with a current stock price of $4.78.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In